Suppr超能文献

肾功能正常患者的厄他培南诱发的脑病

Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function.

作者信息

Sutton S Scott, Jumper Mark, Cook Sean, Edun Babatunde, Wyatt Michael D

机构信息

University of South Carolina, Columbia, SC, USA.

Dorn Veterans Affairs Medical Center, Columbia, SC, USA.

出版信息

J Investig Med High Impact Case Rep. 2017 Jan 1;5(1):2324709616689376. doi: 10.1177/2324709616689376. eCollection 2017 Jan-Mar.

Abstract

Drug-induced neurotoxicity is a rare adverse reaction associated with ertapenem. Encephalopathy is a type of neurotoxicity that is defined as a diffuse disease of the brain that alters brain function or structure. We report a patient with renal function who developed ertapenem-induced encephalopathy manifesting as altered mental status, hallucinations, and dystonic symptoms. The patient's symptoms improved dramatically following ertapenem discontinuation, consistent with case reports describing ertapenem neurotoxicity in renal dysfunction. Since clinical evidence strongly suggested ertapenem causality, we utilized the Naranjo Scale to estimate the probability of an adverse drug reaction to ertapenem. Our patient received a Naranjo Scale score of 7, suggesting a probable adverse drug reaction, with a reasonable temporal sequence to support our conclusion.

摘要

药物性神经毒性是与厄他培南相关的一种罕见不良反应。脑病是神经毒性的一种类型,被定义为改变脑功能或结构的弥漫性脑部疾病。我们报告了一名肾功能不全患者,其出现了厄他培南诱发的脑病,表现为精神状态改变、幻觉和张力障碍症状。在停用厄他培南后,患者症状显著改善,这与描述肾功能不全患者中厄他培南神经毒性的病例报告一致。由于临床证据强烈提示厄他培南为病因,我们使用了纳兰霍量表来评估对厄他培南发生药物不良反应的可能性。我们的患者纳兰霍量表评分为7分,提示可能发生了药物不良反应,且有合理的时间顺序来支持我们的结论。

相似文献

1
Ertapenem-Induced Encephalopathy in a Patient With Normal Renal Function.
J Investig Med High Impact Case Rep. 2017 Jan 1;5(1):2324709616689376. doi: 10.1177/2324709616689376. eCollection 2017 Jan-Mar.
2
Probable ertapenem-induced encephalopathy; case report and suggested alternatives for chronic prostatitis.
Daru. 2022 Jun;30(1):159-163. doi: 10.1007/s40199-021-00425-5. Epub 2022 Jan 13.
3
Ertapenem-associated neurotoxicity in the spinal cord injury (SCI) population: A case series.
J Spinal Cord Med. 2018 Nov;41(6):735-740. doi: 10.1080/10790268.2017.1368960. Epub 2017 Sep 6.
4
Ertapenem-induced encephalopathy.
BMJ Case Rep. 2020 Jun 1;13(6):e231875. doi: 10.1136/bcr-2019-231875.
5
Ertapenem-Induced Hallucinations and Delirium in an Elderly Patient.
Consult Pharm. 2016 Apr;31(4):207-14. doi: 10.4140/TCP.n.2016.207.
6
Ertapenem-Induced Neurotoxicity: A Literature Review of Clinical Characteristics and Treatment Outcomes.
Infect Drug Resist. 2023 Jun 8;16:3649-3658. doi: 10.2147/IDR.S406852. eCollection 2023.
7
A Rare Case of Late-Onset Ertapenem-Induced Encephalopathy.
Cureus. 2023 Aug 18;15(8):e43713. doi: 10.7759/cureus.43713. eCollection 2023 Aug.
8
Ceftriaxone-Induced Encephalopathy in a Patient With End-Stage Renal Disease on Hemodialysis.
Cureus. 2023 Sep 29;15(9):e46226. doi: 10.7759/cureus.46226. eCollection 2023 Sep.
9
Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism.
Int J Clin Pharm. 2013 Aug;35(4):535-7. doi: 10.1007/s11096-013-9812-x. Epub 2013 Jun 26.
10
Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
Pharmacotherapy. 2007 Aug;27(8):1202-5. doi: 10.1592/phco.27.8.1202.

引用本文的文献

1
Ertapenem-induced encephalopathy in a patient with liver abscess and acute kidney injury.
BMJ Case Rep. 2024 Jan 3;17(1):e256876. doi: 10.1136/bcr-2023-256876.
2
A Rare Case of Late-Onset Ertapenem-Induced Encephalopathy.
Cureus. 2023 Aug 18;15(8):e43713. doi: 10.7759/cureus.43713. eCollection 2023 Aug.
3
Abnormal inpatient EEG predicts seizure occurrence independently of renal function.
Epilepsy Behav Rep. 2023 Aug 5;23:100615. doi: 10.1016/j.ebr.2023.100615. eCollection 2023.
4
Peripheral Neuropathy Secondary to Ertapenem Administration for Treatment of Infectious Endocarditis.
Cureus. 2023 Apr 7;15(4):e37253. doi: 10.7759/cureus.37253. eCollection 2023 Apr.
5
Probable ertapenem-induced encephalopathy; case report and suggested alternatives for chronic prostatitis.
Daru. 2022 Jun;30(1):159-163. doi: 10.1007/s40199-021-00425-5. Epub 2022 Jan 13.
6
Ertapenem-induced encephalopathy.
BMJ Case Rep. 2020 Jun 1;13(6):e231875. doi: 10.1136/bcr-2019-231875.
7
Successful Use of Ertapenem for the Treatment of Complex Infection of the Central Nervous System (CNS).
Case Rep Infect Dis. 2019 Nov 5;2019:7021586. doi: 10.1155/2019/7021586. eCollection 2019.

本文引用的文献

2
Ertapenem-associated psychosis and encephalopathy.
Intern Med J. 2014 Aug;44(8):817-9. doi: 10.1111/imj.12504.
3
The risk of seizures among the carbapenems: a meta-analysis.
J Antimicrob Chemother. 2014 Aug;69(8):2043-55. doi: 10.1093/jac/dku111. Epub 2014 Apr 16.
4
Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism.
Int J Clin Pharm. 2013 Aug;35(4):535-7. doi: 10.1007/s11096-013-9812-x. Epub 2013 Jun 26.
6
Neurotoxic effects associated with antibiotic use: management considerations.
Br J Clin Pharmacol. 2011 Sep;72(3):381-93. doi: 10.1111/j.1365-2125.2011.03991.x.
8
Central nervous system toxicity associated with ertapenem use.
Ann Pharmacother. 2011 Jan;45(1):e6. doi: 10.1345/aph.1P528. Epub 2010 Dec 21.
9
A case of beta lactam-induced visual hallucination.
N Z Med J. 2009 Jul 3;122(1298):76-7.
10
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
Toxicology. 2006 May 1;222(1-2):114-24. doi: 10.1016/j.tox.2006.02.004. Epub 2006 Mar 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验